๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prostate-specific antigen: A prognostic factor and outcome marker for prostate cancer treated with radiation therapy

โœ Scribed by Vivek S. Kavadi; Gunar K. Zagars; Allan Pollack

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
111 KB
Volume
30
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prostate specific antigen density as a p
Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy
โœ Alan Pollack; Scott Lankford; Gunar K. Zagars; R. Joseph Babaian ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 632 KB

## BACKGROUND. The pretreatment serum prostate specific antigen level (PSAL) is the most significant predictor of biochemical and local failure in patients treated with definitive radiotherapy. The role of prostate specific antigen (PSA) density (PSAD) relative to PSAL for such patients is controv

The fall and rise of prostate-specific a
The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer
โœ Gunar K. Zagars; Alan Pollack ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O